Representative before the EPO

Employment test 51 - 200 employees
Company dna barker brettell llp
no operation time available
Headquarter in Birmingham and 6 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Jennifer Atkinson has worked on the following 234 EPO patent applications which have been published in the last five years:

EP11753805

SUBTERRANEAN FORMATION DEFORMATION MONITORING SYSTEMS

IPC classification:
E21B 47/00
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP11787264

MUTANT NGAL PROTEINS AND USES THEREOF

IPC classification:
C07K 1/00
Applicant:
The Trustees of Columbia University in the City of New York
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP11804436

METHODS FOR THE PREVENTION OR TREATMENT OF NO-REFLOW FOLLOWING ISCHEMIA/REPERFUSION INJURY

IPC classification:
A61K 38/07, A61P 9/10
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP11764841

IMMUNOGENIC COMPOSITION COMPRISING NEISSERIA MENIGITIDIS MACROPHAGE INFECTIVITY POTENTIATOR PROTEIN

IPC classification:
A61K 39/095, A61P 31/04
Applicant:
University of Southampton
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP11166718

Methods for Regulation of Stem Cells

IPC classification:
C12N 5/16, C12Q 1/68
Applicant:
The University of Washington
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11748191

MITOCHONDRIAL-TARGETED ANTIOXIDANTS PROTECT AGAINST MECHANICAL VENTILATION-INDUCED DIAPHRAGM DYSFUNCTION AND SKELETAL MUSCLE ATROPHY

IPC classification:
A61K 38/06, A61P 21/00, A61P 39/06
Applicant:
Cornell University
Applicant:
University of Florida Research Foundation, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11839687

FUSION PROTEINS COMPRISING AN ENGINEERED KNOTTIN PEPTIDE AND USES THEREOF

IPC classification:
C12P 21/04
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP12823234

DEXMEDETOMIDINE PREMIX FORMULATION

IPC classification:
A01N 43/50, A01N 43/58, A61K 31/50
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP11808284

DISULFIRAM FORMULATION AND USES THEREOF

IPC classification:
A61K 9/127, A61K 9/51, A61K 31/145, A61P 35/00
Applicant:
University of Wolverhampton
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP11806181

HUMAN PAPILLOMAVIRUS E7 ANTIGEN COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 39/12, A61K 39/295, A61P 31/20, A61P 37/04, C07K 14/025, C12N 15/37, C12N 15/62, C12Q 1/70, G01N 33/564, G01N 33/569
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12738913

RECOMBINANT T CELL LIGANDS AND ANTIBODIES THAT BIND B CELLS FOR THE TREATMENT OF AUTOIMMUNE DISEASES

IPC classification:
A61K 38/17, A61K 39/00, A61K 39/395, A61P 37/02
Applicant:
Oregon Health & Science University - Office of Technology Transfer and Business Development
Applicant:
The United States of America Represented by the Department of Veterans Affairs
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP12177074

Balanol compounds for use in treating pain

IPC classification:
A61K 31/55, A61K 38/04, A61K 38/06, A61K 38/07, A61K 38/08, A61K 38/10, A61K 38/16, A61K 38/46
Applicant:
The Trustees of Columbia University in the City of New York
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP13759967

COMPOSITIONS AND METHODS FOR IDENTIFYING AND COMPARING MEMBERS OF MICROBIAL COMMUNITIES BY COMPUTATIONAL ANALYSIS OF AMPLICON SEQUENCES

IPC classification:
C12N 1/20, C12Q 1/04, C12Q 1/68, G06F 17/00
Agent:
Andrew Bentham, J A Kemp
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
PATENT GRANTED
EP12770802

POLYMER CONJUGATED PROSTAGLANDIN ANALOGUES

IPC classification:
A61K 31/557, A61K 47/48, A61P 27/06, C07C 405/00
Applicant:
Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12774724

ANTIBODIES AND OTHER MOLECULES THAT BIND B7-H1 AND PD-1

IPC classification:
A61K 39/395, C07K 16/28, C07K 16/30
Applicant:
MedImmune, LLC
Agent:
Jane Harriet Evenson, Mathys & Squire LLP
Agent:
Multiple attorneys, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP12172058

Procurement, isolation and cryopreservation of endometrial/menstrual cells

IPC classification:
A61Q 19/00, C12N 5/07, G01N 33/50
Agent:
Multiple attorneys, HGF Limited
Agent:
Jennifer Atkinson, Barker Brettell LLP
Agent:
Multiple attorneys, Harrison Goddard Foote LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11822754

RECOMBINANT T-CELL RECEPTOR LIGANDS WITH COVALENTLY BOUND PEPTIDES

IPC classification:
A61K 38/28, A61K 39/00, A61K 39/385, A61P 3/10, C07K 14/74, C07K 19/00
Applicant:
Oregon Health & Science University - Office of Technology Transfer and Business Development
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP12710989

OIL BODY EXTRACTION AND USES

IPC classification:
A23L 1/30, A61K 8/04, A61Q 19/00, C11B 1/10
Applicant:
University of Nottingham
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP11763511

CELL THERAPY TO IMPROVE WOUND HEALING AND RELATED COMPOSITIONS AND METHODS

IPC classification:
A61K 35/14, A61P 17/02, C12N 5/071
Agent:
Multiple attorneys, HGF Limited
Agent:
Jennifer Atkinson, Barker Brettell LLP
Agent:
Multiple attorneys, Harrison Goddard Foote LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12800222

NOVEL RODENT CONTROL AGENTS AND USES THEREOF

IPC classification:
A01M 29/12, A01N 33/02, A01P 11/00
Applicant:
President and Fellows of Harvard College
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14155476

Aromatic-cationic peptides and uses of same

IPC classification:
A61K 38/07, A61K 38/08, A61P 39/06, C07K 5/11, C07K 7/00
Applicant:
Cornell University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12832834

METHOD FOR THE EX VIVO EXPANSION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS

IPC classification:
C12N 5/078, C12N 5/0789
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP12842044

FIBRE-FORMING PROCESS AND FIBRES PRODUCED BY THE PROCESS

IPC classification:
D01D 5/06, D01D 5/26, D01D 5/40, D01F 1/00, D01F 2/00, D01F 6/00
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP12835846

AROMATIC-CATIONIC PEPTIDES AND METHODS FOR USING SAME

IPC classification:
A61K 38/00, A61K 38/04, C07K 5/00
Applicant:
Stealth Peptides International, Inc.
Applicant:
Mayo Foundation for Medical Education and Research
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP12836110

CHLAMYDIA ANTIGEN COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 39/118, A61P 31/04, A61P 37/04
Applicant:
The University of British Columbia
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13188850

Differentiated anucleated cells and method for preparing the same

IPC classification:
C12N 5/00, C12N 5/10
Agent:
Richard Pietro Leoni, Avidity IP Ltd
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14151500

Methods for the prevention or treatment of heart failure

IPC classification:
A61K 38/00, A61K 38/07, A61K 45/06, C07K 5/09, C07K 5/107, C07K 5/11
Applicant:
University of Washington CoMotion
Applicant:
Cornell University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13162492

Agents for preventing and treating disorders Involving modulation of the RYR receptors

IPC classification:
A61K 31/553, A61P 9/00, C07D 281/02, C07D 281/10, C07D 417/12, C07D 417/14
Applicant:
The Trustees of Columbia University in the City of New York
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP12841561

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

IPC classification:
A61K 38/00, A61K 38/04, C07K 5/00
Applicant:
Stealth Peptides International, Inc.
Applicant:
Cornell University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP12790972

A METHOD OF DETECTING AND/OR QUANTIFYING AN ANALYTE IN A BIOLOGICAL SAMPLE

IPC classification:
G01N 33/543, G01N 33/553, G01N 33/94
Applicant:
University of Cape Town
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP12848329

COMPOSITE TISSUE GRAFT AND MATERIALS AND METHODS FOR ITS PRODUCTION AND USE

IPC classification:
A61F 2/02, A61L 27/18, A61L 27/38, A61L 27/54, C12M 3/00, C12N 5/07, C12N 11/02
Applicant:
The General Hospital Corporation
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP12855211

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

IPC classification:
A61K 38/07
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12863654

FILTER AND FRAME APPARATUS AND METHOD OF USE

IPC classification:
A61M 1/34
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
PATENT GRANTED
EP13700425

PARTIAL MHC CONSTRUCTS AND METHODS OF USE

IPC classification:
A61K 39/00, C07K 14/74
Applicant:
Oregon Health & Science University
Applicant:
The United States of America Represented by the Department of Veterans Affairs
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP13703459

BIOMARKER AND USES THEREOF

IPC classification:
G01N 33/574
Applicant:
Oxford University Innovation Ltd
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13735786

ISOLATED HUMAN LUNG PROGENITOR CELLS AND USES THEREOF

IPC classification:
A61K 35/42, A61K 48/00, A61P 11/00, C12N 5/071, C12N 5/077, C12Q 1/68
Applicant:
The General Hospital Corporation
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13189441

Novel 1 -naphthyl-3-azabicyclo[3.1.0]hexanes:preparation and use to treat neurophychiatric disorders

IPC classification:
A61K 31/40, A61P 25/00, C07D 209/52
Agent:
Christopher William Bond, Forresters IP LLP
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP11756870

COMBINATION THERAPIES USING CYCLOSPORINE AND AROMATIC CATIONIC PEPTIDES

IPC classification:
A61K 38/06, A61K 38/07, A61K 38/08, A61K 38/13, A61P 9/10
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13744396

RETINALDEHYDE MIMETICS AND INHIBITORS OF RETINALDEHYDE DEHYDROGENASE I IN THE TREATMENT OF DISORDERS

IPC classification:
A61K 31/07, A61K 31/11, A61K 31/711, A61P 3/00
Applicant:
The Brigham and Women's Hospital, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP13742971

FILTER CLEANING SYSTEM AND METHOD

IPC classification:
B01D 24/46, B01D 29/11
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13746674

PRODUCTS OF MANUFACTURE HAVING TANTALUM COATED NANOSTRUCTURES, AND METHODS OF MAKING AND USING THEM

IPC classification:
A61F 2/28, A61L 27/30, A61L 27/38
Applicant:
The Regents of the University of California
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13187459

Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T cells

IPC classification:
A61K 39/00
Applicant:
Oregon Health & Science University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP14164726

Methods and Compositions for Preventing or Treating Ophthalmic Conditions

IPC classification:
A61K 38/07, A61P 27/02, A61P 27/12
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11799965

METHODS, DEVICES AND A MARKER FOR PHYSICAL CONDITION TESTING

IPC classification:
A61B 5/00, A61B 5/02, A61B 5/0205, A61B 5/024, A61B 5/0245, A61B 5/04, A61B 5/0402, A61B 5/22, A63B 24/00
Applicant:
University of South Australia
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP13749864

A SYSTEM AND METHOD OF GENOMIC PROFILING

IPC classification:
C12Q 1/68
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP12814382

METHODS OF TREATING PAIN

IPC classification:
A61K 9/00, A61K 9/08, A61K 31/196, A61K 31/724, A61K 47/40
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13751525

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

IPC classification:
A61K 38/07
Applicant:
Cornell University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP13751091

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS

IPC classification:
A61K 38/00, A61K 38/13
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14181858

Methods and compositions for preventing or treating ophthalmic conditions

IPC classification:
A61K 38/07, A61P 27/02, A61P 27/12
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13191686

Factor VIII B cell epitope variants having reduced immunogenicity

IPC classification:
A61K 38/37
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13769804

METHODS FOR TREATING HAIR LOSS DISORDERS

IPC classification:
A61K 39/395
Applicant:
The Trustees of Columbia University in the City of New York
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP13718612

VECTOR

IPC classification:
C12N 15/74, C12N 15/90
Applicant:
University of Nottingham
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP13718611

BACTERIAL EXPRESSION SYSTEM

IPC classification:
C12N 15/63
Applicant:
University of Nottingham
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13769696

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT NEUROPATHY

IPC classification:
A61K 38/07
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
PATENT GRANTED
EP13771865

SYSTEMS AND METHOD FOR ENGINEERING MUSCLE TISSUE

IPC classification:
A61F 2/08, A61L 27/14, A61L 27/38
Applicant:
University of Washington CoMotion
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13774960

METHODS AND APPARATUS FOR ISOLATION OF WHITE BLOOD CELLS

IPC classification:
A61J 1/05, A61M 1/02, B04B 1/00, B04B 7/08
Applicant:
President and Fellows of Harvard College
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13775320

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

IPC classification:
A61K 38/07
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13721794

COMPOSITION

IPC classification:
A23L 2/00, A23L 2/02, A23L 2/38, A23L 2/52
Agent:
Richard Alan Wilding, K2 IP Ltd
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP13776210

CONTAINER LINER SYSTEMS

IPC classification:
B65D 88/12, B65D 90/02
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13778033

TREATMENT OF MEDIUM-CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY

IPC classification:
A61K 31/06, A61K 31/12, A61P 3/00
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP12822276

CHLOROBIS COPPER (I) COMPLEX COMPOSITIONS AND METHODS OF MANUFACTURE AND USE

IPC classification:
A61K 31/30, A61K 31/444, A61P 19/02, A61P 21/00, A61P 25/20, A61P 25/24, A61P 25/28, C07F 1/00, C07F 1/08
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13781584

PHONE CAMERA AND SAMPLE STAND

IPC classification:
G03B 17/12
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13727317

IMPLANT

IPC classification:
A61B 17/68, A61L 31/12
Applicant:
University of Nottingham
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP14194189

Aromatic-cationic peptides and uses of same

IPC classification:
A61K 38/07, A61K 38/08, A61P 39/06, C07K 5/11, C07K 7/00
Applicant:
Cornell University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13787969

CONFORMATIONALLY SPECIFIC VIRAL IMMUNOGENS

IPC classification:
A61K 39/12, A61K 39/42, C12N 7/01
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP13732603

BIOMARKER SPAG5

IPC classification:
C12Q 1/68, G01N 33/574
Applicant:
Nottingham University Hospitals NHS Trust
Applicant:
Nottingham Trent University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13805049

MAGNETIC EXTRACELLULAR MATRIX

IPC classification:
A61B 17/52, A61N 2/00
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP13787995

SYSTEM AND APPARATUS FOR ANALYSIS OF A GUAYULE PLANT IN SITU& xA;

IPC classification:
G01N 21/61
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13742259

BIOMARKERS FOR DETERMINING THE M. TUBERCULOSIS INFECTION STATUS

IPC classification:
C12Q 1/68
Applicant:
Nottingham Trent University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP13809852

COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ABERRANT LIPOGENIC SIGNALING

IPC classification:
A61K 31/69, A61P 35/00, C07F 5/02, C07F 5/04
Applicant:
Thomas Jefferson University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP14195944

Synthetic ligation reassembly in directed evolution

IPC classification:
C12N 15/10
Applicant:
BP Corporation North America Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13744773

LIPOCALIN-2 AS A BIOMARKER FOR PNEUMOCOCCAL INFECTION STATUS AND USES THEREOF

IPC classification:
G01N 33/569
Applicant:
Oxford University Innovation Ltd
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13820331

ENHANCED RECONSTITUTION AND AUTORECONSTITUTION OF THE HEMATOPOIETIC COMPARTMENT

IPC classification:
A61K 35/14, C07K 19/00, C12N 5/02, C12N 5/078
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13825389

METHODS FOR TREATMENT OF ATHEROSCLEROSIS

IPC classification:
A61K 38/08
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13824883

METHODS FOR TREATMENT OF ATHEROSCLEROSIS

IPC classification:
A61K 38/00
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13826181

MODULATION OF THE IMMUNE RESPONSE

IPC classification:
A61K 39/395, A61K 48/00, A61P 37/02, A61P 37/04, C07K 14/00
Applicant:
The Brigham and Women's Hospital, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13765388

NEISSERIA MENINGITIDIS FHBP VARIANT AND ITS USE FOR VACCINATION

IPC classification:
A61K 39/095, C07K 14/22, C12N 15/00
Applicant:
Oxford University Innovation Ltd
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP14191058

Composition and methods for clotting blood

IPC classification:
A61K 9/00, A61K 36/00, A61K 36/185, A61K 36/28, A61K 36/53, A61L 26/00, A61P 9/14, A61P 11/02, A61P 17/02
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP13833184

GLYCOSIDASE INHIBITORS AND USES THEREOF

IPC classification:
A61K 31/445, A61K 31/4523, A61P 25/28, C07D 211/56, C07D 401/06, C07D 417/06, C07H 13/02, C12N 9/24
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Alectos Therapeutics Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13833758

GLYCOSIDASE INHIBITORS AND USES THEREOF

IPC classification:
A61K 31/445, A61P 25/28, C07D 211/60, C07H 5/04, C07H 7/00, C12N 9/24
Applicant:
Merck Sharp & Dohme Corporation
Applicant:
Alectos Therapeutics Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13834586

CHAIR WITH ADJUSTABLE BACKREST AND SEAT

IPC classification:
A47C 1/024, A47C 1/032
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13836308

METHODS FOR MULTIPLEX ANALYTICAL MEASUREMENTS IN SINGLE CELLS OF SOLID TISSUES

IPC classification:
C12N 5/00, C12Q 1/04, C12Q 1/24
Applicant:
President and Fellows of Harvard College
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13848800

SYNTHETIC ENV PROTEINS

IPC classification:
C07K 14/155, C07K 16/10
Applicant:
Dana-Farber Cancer Institute, Inc.
Applicant:
Duke University
Agent:
Michael Schneider, Heisse Kursawe Eversheds
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP14197465

Methods for performing a coronary artery bypass graft procedure

IPC classification:
A61K 38/07, A61P 9/10
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14188202

Compositions and methods for treating beta-amyloid related diseases

IPC classification:
A61K 31/336, A61P 25/28, C07D 303/18, C07D 303/48
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP11751510

INHIBITORY RNAS TO RNA BINDING PROTEINS HNRNPA1, HNRNPA2 AND PTB AND USES THEREOF

IPC classification:
A61K 48/00, C12N 15/113
Applicant:
The Trustees of Columbia University in the City of New York
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13861220

PEPTIDE THERAPEUTICS AND METHODS FOR USING SAME

IPC classification:
A61P 39/06
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14843196

ADDITIVE COMPOSITIONS AND INDUSTRIAL PROCESS FLUIDS

IPC classification:
C10M 133/04, C10M 133/06
Agent:
Jennifer Atkinson, Barker Brettell LLP
Agent:
mepat Partnerschaftsgesellschaft Dr. Mehl-Mikus, Goy, Dr. Drobnik mbB
Status:
GRANT OF PATENT INTENDED
EP11778123

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

IPC classification:
A61K 38/05, A61K 38/06, A61K 38/07, A61P 3/00, A61P 5/50, A61P 9/10, A61P 25/16, A61P 25/28, C07K 5/065, C07K 5/068, C07K 5/087, C07K 5/09, C07K 5/103, C07K 5/107, C07K 5/11
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13812436

METHODS AND COMPOSITIONS OF PROTEIN ANTIGENS FOR THE DIAGNOSIS AND TREATMENT OF LEPTOSPIROSIS

IPC classification:
A61K 39/02, C07K 14/20
Applicant:
Yale University
Applicant:
The Regents of the University of California
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12187097

Methods for generation of antibodies

IPC classification:
A01K 67/00, A01K 67/027, A01K 67/033
Agent:
James Christopher Legg, Avidity IP Ltd
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15160602

Aromatic-Cationic Peptides and Uses of Same

IPC classification:
A61K 38/05, A61K 38/06, A61K 38/07, A61P 3/00, A61P 5/50, A61P 9/10, A61P 25/16, A61P 25/28, C07K 5/065, C07K 5/068, C07K 5/087, C07K 5/09, C07K 5/103, C07K 5/107, C07K 5/11
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15154763

Methods for the prevention or treatment of heart failure

IPC classification:
A61K 38/00, A61K 38/07, A61K 45/06, C07K 5/09, C07K 5/107
Applicant:
University of Washington CoMotion
Applicant:
Cornell University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14707429

COMPOSITION AND USES THEREOF

IPC classification:
A61K 39/015, C07K 14/445
Applicant:
Oxford University Innovation Ltd
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP14749292

CRYSTAL COMESTIBLE PRODUCT AND METHOD OF MAKING SAME

IPC classification:
A23L 1/22
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP14751631

CENTRALLY ACTIVE AND ORALLY BIOAVAILABLE ANTIDOTES FOR ORGANOPHOSPHATE EXPOSURE AND METHODS FOR MAKING AND USING THEM

IPC classification:
A61K 31/46, A61P 25/00, C07D 225/02, C07D 403/02
Applicant:
The Regents of the University of California
Applicant:
The Scripps Research Institute
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15174180

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPTHALMIC CONDITIONS

IPC classification:
A61K 38/07, A61P 27/02, A61P 27/12
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14754450

COMPOSITIONS AND METHODS FOR INHIBITING TUMOR CELLS BY INHIBITING THE TRANSCRIPTION FACTOR ATF5

IPC classification:
A01N 63/00, A01N 65/00
Applicant:
The Trustees of Columbia University in the City of New York
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP13862686

METHODS AND ASSAYS RELATING TO MACROPHAGE DIFFERENTIATION

IPC classification:
A61K 31/435, A61K 38/20, A61K 38/21, A61P 9/00, A61P 29/00, A61P 37/00, A61P 43/00, C12N 5/071, G01N 33/50
Applicant:
The Brigham and Women's Hospital, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15177582

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPTHALMIC CONDITIONS

IPC classification:
A61K 38/07, A61P 27/02, A61P 27/12
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14756991

METHODS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF BARTH SYNDROME

IPC classification:
A61K 38/06
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14757000

METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE

IPC classification:
A61K 8/64, A61K 38/07, C07K 5/10, C07K 5/11
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14761076

PTD-SMAD7 THERAPEUTICS

IPC classification:
C12P 19/34
Applicant:
The Regents of the University of Colorado
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14759837

CYTOMEGALOVIRUS VECTORS ENABLING CONTROL OF T CELL TARGETING

IPC classification:
A61K 48/00, C12N 15/12, C12N 15/86
Applicant:
Oregon Health & Science University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14761090

AN APPARATUS FOR PRODUCING NANO-BODIES

IPC classification:
B82Y 40/00, D01D 5/40, D01F 1/00, D02G 3/02
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15175802

MODULATORS OF MYC, METHODS OF USING THE SAME AND METHODS OF IDENTIFYING AGENTS THAT MODULATE MYC

IPC classification:
A61K 38/16, C07K 14/82, C07K 19/00
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP14762460

TARGETING THE mTOR PATHWAY IN NEUROLOGICAL DISEASE

IPC classification:
A61K 31/497, A61K 31/519, C07D 471/04
Applicant:
The Trustees of Columbia University in the City of New York
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14769755

CARBOHYDRATE-MODIFIED GLYCOPROTEINS AND USES THEREOF

IPC classification:
C07G 3/00
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14779483

EXPANSION OF ADULT STEM CELLS IN VITRO

IPC classification:
C12N 5/00, C12N 5/071
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14776214

BISPECIFIC MOLECULES THAT ARE IMMUNOREACTIVE WITH IMMUNE EFFECTOR CELLS THAT EXPRESS AN ACTIVATING RECEPTOR

IPC classification:
A01N 65/00, A61K 39/00, A61K 39/12, A61K 39/38, A61K 45/00, C12N 5/07, C12N 5/16, C12N 7/00, C12N 7/01
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14778538

THE PRODUCTION AND USE OF RED BLOOD CELLS

IPC classification:
A01N 63/00, C12N 5/00, C12N 5/071
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15184260

ANTIBODIES REACTIVE WITH B7-H3, IMMUNOLOGICALLY ACTIVE FRAGMENTS THEREOF AND USES THEREOF

IPC classification:
A61K 39/00, C07K 16/28, C07K 16/30
Agent:
Ross Martin Cummings, Avidity IP Ltd
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14716624

COMPOSITION AND USE

IPC classification:
A23L 33/00, A23L 33/17, A23L 29/30
Applicant:
University of Nottingham
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP14783183

THERAPEUTIC VIRAL MICROPARTICLES FOR PROMOTING STENT BIOFUNCTIONALITY AND WOUND HEALING IN VERTEBRATE INDIVIDUALS

IPC classification:
A61K 9/14, A61K 31/7088, A61K 35/76, A61K 38/18, A61K 47/34, A61L 31/08, A61L 31/14, A61P 17/02, C12N 7/01, C12N 11/08, C12N 15/866
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14785372

MEDIA COMPOSITIONS FOR NEURONAL CELL CULTURE

IPC classification:
C12N 5/079, C12N 5/0793, C12N 5/0797
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14784929

ACTIVATING AN ALTERNATIVE PATHWAY FOR HOMOLOGY-DIRECTED REPAIR TO STIMULATE TARGETED GENE CORRECTION AND GENOME ENGINEERING

IPC classification:
C12N 5/00, C12N 5/02, C12P 19/34
Applicant:
University of Washington CoMotion
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15172384

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPTHALMIC CONDITIONS

IPC classification:
A61K 38/07, A61P 27/02, A61P 27/12
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14779382

EXPRESSION OF HIV INHIBITORS BY MESENCHYMAL STEM CELLS

IPC classification:
A61K 35/12, A61K 39/395, A61P 31/12, A61P 31/18
Applicant:
Tulane University - Technology Transfer & Intellectual Property Developmen
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14791131

METHOD OF TREATING DISEASE BY AURICULAR ANESTHESIA OF CRANIAL NERVES

IPC classification:
A61K 9/00
Agent:
Ekkehard Heinze, Meissner Bolte & Partner GbR
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14764005

DEVICE AND METHODS COMPRISING MICROELECTRODE ARRAYS FOR ELECTROCONDUCTIVE CELLS

IPC classification:
C12M 3/00
Applicant:
University of Washington CoMotion
Applicant:
The Arizona Board Of Regents On Behalf Of The University Of Arizona
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14737297

ALKYL QUINOLONES AS BIOMARKERS OF PSEUDOMONAS AERUGINOSA INFECTION AND USES THEREOF

IPC classification:
G01N 33/68
Applicant:
University of Nottingham
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP14798141

HUMAN PLURIPOTENT STEM CELLS PRODUCED BY SOMATIC CELL NUCLEAR TRANSFER

IPC classification:
C12N 5/02, C12N 5/074
Applicant:
Oregon Health & Science University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP13884895

METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING

IPC classification:
A61K 38/06
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14797206

SYSTEMS AND METHODS FOR DELIVERING BONE CONDUCTION STIMULI TO AND FOR MEASURING GRAVITATION RECEPTOR FUNCTIONS OF THE INNER EAR

IPC classification:
A61B 3/10, A61B 5/12, A61B 9/00, A61B 10/00
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP11769542

BIOMARKERS BASED ON A MULTI-CANCER INVASION-ASSOCIATED MECHANISM

IPC classification:
C12Q 1/68, G01N 33/50
Applicant:
The Trustees of Columbia University in the City of New York
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14808337

PEG-PROM MEDIATED SURFACE EXPRESSION OF AVIDIN/STREPTAVIDIN

IPC classification:
C12N 15/64
Applicant:
Johns Hopkins University
Applicant:
Virginia Commonwealth University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP14817622

USE OF A TRUNCATED CCN1 PROMOTER FOR CANCER DIAGNOSTICS, THERAPEUTICS AND THERANOSTICS

IPC classification:
A01K 67/027
Applicant:
Virginia Commonwealth University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP14807031

RECOMBINANT CANCER THERAPEUTIC CYTOKINE

IPC classification:
C07K 14/52
Applicant:
Virginia Commonwealth University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP14807809

MDA-9/SYNTENIN PROMOTER TO IMAGE AND TREAT METASTATIC CANCER CELLS

IPC classification:
G01N 33/48
Applicant:
Virginia Commonwealth University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP15177562

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

IPC classification:
A61K 38/07, A61P 25/28, A61P 39/06, C07K 5/065, C07K 5/068, C07K 5/087, C07K 5/09, C07K 5/107, C07K 5/11
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14814507

PYRROLOQUINAZOLINE COMPOUNDS

IPC classification:
A61K 31/519, C07D 487/04
Applicant:
Oregon Health & Science University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP14801627

ENGINEERED HEME-BINDING COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 38/00, C07K 14/805
Applicant:
President and Fellows of Harvard College
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14818293

LABELED PKG-1-ALPHA-BINDING COMPOUNDS AND THEIR USE IN IMAGING AND QUANTIFYING PAIN

IPC classification:
A61K 31/40, A61K 31/416
Applicant:
The Trustees of Columbia University in the City of New York
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP14819961

SOLUBLE MIC NEUTRALIZING MONOCLONAL ANTIBODY FOR TREATING CANCER

IPC classification:
A61K 39/395, C07H 21/04, C07K 16/00, C12P 21/08
Applicant:
University of Washington CoMotion
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP15185546

AROMATIC-CATIONIC PEPTIDES AND USES OF SAME

IPC classification:
A61K 38/07, A61K 38/08, A61P 39/06, C07K 5/11, C07K 7/00
Applicant:
Cornell University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11750124

OLIGOMER-SPECIFIC AMYLOID BETA EPITOPE AND ANTIBODIES

IPC classification:
A61K 39/00, A61K 39/395, A61K 45/06, A61P 25/28, A61P 37/04, C07K 7/06, C07K 7/64, C07K 14/47, C07K 16/18, C12N 15/13, G01N 33/53, G01N 33/68
Applicant:
The University of British Columbia
Agent:
Marion Chajmowicz, Cabinet Becker & Associés
Agent:
Ross Thomson Walker, Forresters IP LLP
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11757919

IDENTIFICATION OF LIGANDS AND THEIR USE

IPC classification:
G01N 33/569
Applicant:
Oxford University Innovation Ltd
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16154206

TAILORED MULTI-SITE COMBINATIONAL ASSEMBLY

IPC classification:
C12N 15/10, C12P 19/34
Applicant:
BP Corporation North America Inc.
Applicant:
BASF Enzymes LLC
Agent:
Andrea Gisela Lasar, Maiwald Patentanwalts GmbH
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP14834798

BI-SPECIFIC MONOVALENT FC DIABODIES THAT ARE CAPABLE OF BINDING CD32B AND CD79B AND USES THEREOF

IPC classification:
A61K 39/395
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP14765985

COMPOSITION AND DELIVERY SYSTEM

IPC classification:
A61L 27/50
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP14837931

IMMUNO-ONCOLYTIC THERAPIES

IPC classification:
A61K 39/285, C12N 15/39
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP14837858

BI-SPECIFIC MONOVALENT DIABODIES THAT ARE CAPABLE OF BINDING CD123 AND CD3, AND USES THEROF

IPC classification:
A61K 39/395, C07K 16/28, C07K 17/14
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP15187915

COMBINATION THERAPIES USING CYCLOSPORINE AND AROMATIC CATIONIC PEPTIDES

IPC classification:
A61K 38/06, A61K 38/07, A61K 38/08, A61K 38/13, A61P 9/10
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION PUBLISHED
EP14840432

SINGLE MOLECULE-OVERLAPPING READ ANALYSIS FOR MINOR VARIANT MUTATION DETECTION IN PATHOGEN SAMPLES

IPC classification:
A61K 39/04
Applicant:
Arizona Board Of Regents Acting For And On Behalf Of Northern Arizona University
Applicant:
The Regents of the University of California
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP14841451

TREATMENT AND PREVENTION OF AUTISM AND AUTISM SPECTRUM DISORDERS

IPC classification:
A61P 25/28
Applicant:
The Rockefeller University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP16156951

BCR-COMPLEX-SPECIFIC ANTIBODIES AND METHODS OF USING SAME

IPC classification:
C07K 16/28, C12P 21/08
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14846174

TREATMENT OF INFLAMMATORY SKIN DISEASE

IPC classification:
A61P 37/00
Applicant:
Children's Medical Center Corporation
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14849379

HIV-1 MOTHER-TO-CHILD TRANSMISSION CORRELATES OF PROTECTION AND VACCINE

IPC classification:
A61K 31/7088, A61P 31/18, C07K 14/16, C12N 15/49, G01N 33/50
Applicant:
Duke University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP14847855

USE OF AROMATIC-CATIONIC PEPTIDES TO TREAT CHOLESTEROL-INDUCED MITOCHONDRIAL DYSFUNCTION

IPC classification:
A61K 38/00, A61K 38/06
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP14848640

CARDIOLIPIN-TARGETED PEPTIDES INHIBIT BETA-AMYLOID OLIGOMER TOXICITY

IPC classification:
A61K 38/00, A61K 38/04
Applicant:
Center for Technology Licensing (CTL) at Cornell University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP14789348

MYCOBACTERIA DETECTION USING BACTERIOPHAGES

IPC classification:
C12Q 1/68
Applicant:
University of Nottingham
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14850471

RECOMBINANT POLYPEPTIDES COMPRISING MHC CLASS II 1 DOMAINS

IPC classification:
A61K 38/17, A61P 35/00, C07K 19/00, C12N 15/62
Applicant:
Oregon Health & Science University
Applicant:
The United States of America Represented by the Department of Veterans Affairs
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP14781640

SCAFFOLD

IPC classification:
A61L 27/18, A61L 27/56
Applicant:
Oxford University Innovation Ltd
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP14851197

TREATMENT OF ISCHEMIC STROKE WITH DR 1-MOG-35-55

IPC classification:
A61K 48/00, A61P 9/00, A61P 9/10
Applicant:
Oregon Health & Science University
Applicant:
The United States of America Represented by the Department of Veterans Affairs
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP14852109

COMPUTER IMPLEMENTED METHOD, COMPUTER SYSTEM AND SOFTWARE FOR REDUCING ERRORS ASSOCIATED WITH A SITUATED INTERACTION

IPC classification:
G06F 17/28
Applicant:
President and Fellows of Harvard College
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
GRANT OF PATENT INTENDED
EP14853603

CATALYTIC SCAVENGERS OF ORGANOPHOSPHATES TO POTENTIATE BUTYRYLCHOLINESTERASE (BCHE) AS A CATALYTIC BIOSCAVENGER AND METHODS FOR MAKING AND USING THEM

IPC classification:
A01N 33/24, A61K 31/15, A61K 31/415
Applicant:
The Regents of the University of California
Applicant:
The Scripps Research Institute
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14802103

GLYCANS AS FUNCTIONAL CANCER TARGETS AND ANTIBODIES THERETO

IPC classification:
A61K 39/395, A61P 35/00, C07H 13/02, C07K 16/28, C07K 16/30
Applicant:
University of Nottingham
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP16150396

METHODS FOR PREVENTING OR TREATING METABOLIC SYNDROME

IPC classification:
A61K 38/04, A61K 38/07
Applicant:
Cornell University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION PUBLISHED
EP12183946

Noninvasive diagnosis of fetal aneuploidy by sequencing

IPC classification:
C12Q 1/68
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Desmond Mark Chapman, Carpmaels & Ransford LLP
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
PATENT GRANTED
EP10855180

PROCESS FOR PRODUCING ALDEHYDES OR KETONES BY OXIDIZING ALCOHOLS WITH OXYGEN

IPC classification:
B01J 31/02, B01J 31/26, C07C 45/29, C07C 45/37, C07C 45/38, C07C 45/39, C07C 47/00, C07C 49/00
Applicant:
East China Normal University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12171813

Identification and engineering of antibodies with variant Fc regions and methods of using same

IPC classification:
A61K 39/00, A61K 39/395, C07H 21/04, C07K 16/00, C07K 16/28, C07K 16/32, C07K 16/44, C07K 17/00, C12N 15/00, C12Q 1/68, G01N 33/574
Agent:
Multiple attorneys, Avidity IP Ltd
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11815113

COVALENT DIABODIES AND USES THEREOF

IPC classification:
C07K 16/00, C07K 16/28, C07K 16/32, C07K 19/00
Agent:
Marc George Wilkinson, Avidity IP Ltd
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP14868683

COMPOSITIONS AND METHODS FOR IDENTIFYING AND TREATING CACHEXIA OR PRE-CACHEXIA

IPC classification:
G01N 33/574
Applicant:
Dana-Farber Cancer Institute, Inc.
Applicant:
The Broad Institute, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14868246

COMPOSITIONS AND METHODS FOR ANTIBODY PRODUCTION

IPC classification:
C12P 1/00
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14866993

COMPOSITIONS AND METHODS FOR TREATING VITILIGO

IPC classification:
A61P 17/00
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14809682

MOLECULAR ADJUVANT

IPC classification:
A61K 39/39, A61P 37/04, C07K 14/005
Applicant:
Oxford University Innovation Ltd
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP16159631

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS

IPC classification:
A61K 38/07, A61P 27/02
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION PUBLISHED
EP14861002

COMPOUNDS AND METHODS FOR THE TREATMENT OF MALARIA

IPC classification:
A61K 31/395, C07D 245/00, C07D 487/04
Applicant:
The Broad Institute, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14870945

CAP260, CAP174 AND K0224 HIV-1 ENVELOPES, PEPTIDE AND COMPOSITIONS

IPC classification:
A61K 39/21, C07K 14/155, C12N 15/49, C12N 15/63, C12N 15/863
Applicant:
Duke University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14872915

METHODS AND ASSAYS RELATING TO CIRCULATING TUMOR CELLS

IPC classification:
A61K 38/00, C12Q 1/68, G01N 33/00
Applicant:
The General Hospital Corporation
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14869630

STEM CELL DELIVERED ONCOLYTIC HERPES SIMPLEX VIRUS AND METHODS FOR TREATING BRAIN TUMORS

IPC classification:
A61K 35/76
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14821249

TRANSDUCTION

IPC classification:
A61K 47/48
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14820806

METAGENOMIC ANALYSIS OF SAMPLES

IPC classification:
C12Q 1/68
Applicant:
Université de Liège
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14818949

DETECTION METHODS

IPC classification:
C12Q 1/68
Applicant:
Université de Liège
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP14874049

PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES

IPC classification:
A61K 38/26, A61K 45/06, C07K 14/605
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP16157727

METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY

IPC classification:
A61K 38/07, A61P 9/10, A61P 13/12
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION PUBLISHED
EP14871543

METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING COGNITIVE DYSFUNCTION

IPC classification:
A61K 38/00, A61K 38/08, A61K 38/26
Applicant:
Cornell University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14875963

FUSION GENES ASSOCIATED WITH PROGRESSIVE PROSTATE CANCER

IPC classification:
C12Q 1/68
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15700166

BIOMARKER AND USES THEREOF

IPC classification:
G01N 33/68
Applicant:
Oxford University Innovation Ltd
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15733210

PLATFORM FOR VALIDATING MATERIALS AND CUTTING PROTECTIVE COVERS

IPC classification:
B26D 7/01
Agent:
Grünecker Patent- und Rechtsanwälte PartG mbB
Agent:
Multiple attorneys, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15740843

GOBLET CELL REPLACEMENT THERAPY

IPC classification:
A61K 38/19, A61P 27/02, A61P 27/04, A61P 27/06
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15748950

IMPROVED METHODS FOR THE TREATMENT OF VASCULARIZING CANCERS

IPC classification:
A61K 39/00, A61K 39/395, C12N 5/07, C12P 21/08, G01N 33/569
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15751647

FACTOR VIII B CELL EPITOPE VARIANTS HAVING REDUCED IMMUNOGENICITY

IPC classification:
A61K 38/37, C07K 14/755
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15752063

COMPOUNDS AND METHODS FOR INHIBITING FASCIN

IPC classification:
A61K 31/4245, C07D 231/56
Applicant:
Cornell Center For Technology, Enterprise & Commercialization (CCTEC)
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14884543

PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES

IPC classification:
A61K 38/26, A61K 45/06, C07K 14/605
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15710571

METHODS AND SYSTEM FOR DETERMINING THE DISEASE STATUS OF A SUBJECT

IPC classification:
G01N 33/68
Applicant:
Oxford University Innovation Ltd
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15760641

GENOMIC INSULATOR ELEMENTS AND USES THEREOF

IPC classification:
C12N 15/85
Applicant:
The University of Washington
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15764507

SWARM IMMUNIZATION WITH ENVELOPES FROM CH505

IPC classification:
A61K 39/21, C07K 14/155, C12N 15/46, C12N 15/85
Applicant:
Duke University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP16175746

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPTHALMIC CONDITIONS

IPC classification:
A61K 38/07, A61P 27/02, A61P 27/12
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION PUBLISHED
EP15769306

MOSAIC HIV-1 SEQUENCES AND USES THEREOF

IPC classification:
A61K 39/12, C12N 15/48
Applicant:
Duke University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15768776

COMPOSITIONS AND METHODS FOR TREATING TYPE 1 AND TYPE 2 DIABETES AND RELATED DISORDERS

IPC classification:
A61K 35/39, C12N 5/074, C12N 5/10, C12N 5/22
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15772335

COMPOSITIONS COMPRISING CH848 ENVELOPES AND USES THEREOF

IPC classification:
A61K 31/7088, A61K 39/21, C07K 14/155, C12N 15/49
Applicant:
The Trustees of The University of Pennsylvania
Applicant:
Duke University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15716680

CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING HERPES SIMPLEX VIRUS TYPE 1 (HSV-1)

IPC classification:
C12N 15/113, C12N 15/63
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15772792

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY DISORDERS

IPC classification:
A61P 29/00
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15715927

CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING HIV INFECTION AND AIDS

IPC classification:
A61K 31/7088, C12N 15/113
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP16188059

MUTANT E. COLI STRAIN WITH INCREASED SUCCINIC ACID PRODUCTION

IPC classification:
C12N 1/21, C12P 7/46
Applicant:
William Marsh Rice University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION PUBLISHED
EP15717051

GLYCOLIPIDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR USE IN THERAPY

IPC classification:
A61K 31/7032, A61K 33/24, A61K 45/06, A61P 21/00, A61P 25/00, A61P 25/16, A61P 25/28, A61P 31/12, A61P 35/00, C07H 3/02
Applicant:
University of Nottingham
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP16174236

METHODS FOR TREATMENT OF ATHEROSCLEROSIS

IPC classification:
A61K 31/215, A61K 31/22, A61K 31/351, A61K 31/366, A61K 31/40, A61K 31/404, A61K 31/505, A61K 38/07, A61K 45/06, A61P 9/10
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION PUBLISHED
EP15782472

COMPOSITIONS AND METHODS FOR TREATING SUBJECTS WITH IMMUNE-MEDIATED DISEASES

IPC classification:
C12Q 1/68, G01N 33/53
Applicant:
The Brigham and Women's Hospital, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15783656

CONTRAST REAGENT LEAKAGE CORRECTION IN DYNAMIC SUSCEPTIBILITY CONTRAST MAGNETIC RESONANCE IMAGING

IPC classification:
A61B 5/00, A61B 5/055, G06T 7/00
Applicant:
Oregon Health & Science University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15779219

VACCINE ADJUVANT COMPOSITIONS

IPC classification:
A61K 39/39
Applicant:
Children's Medical Center Corporation
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15785235

RECHARGEABLE FACIAL BRUSH WITH STERILIZATION

IPC classification:
A61H 7/00
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP16192927

ASSAYS FOR FUNGAL INFECTION

IPC classification:
C12Q 1/68
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION PUBLISHED
EP15786070

FUSION PROTEINS FOR TREATING CANCER AND RELATED METHODS

IPC classification:
A61K 39/395, C07K 16/28, A61K 47/50
Applicant:
Dana-Farber Cancer Institute, Inc.
Applicant:
President and Fellows of Harvard College
Agent:
Potter Clarkson LLP
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15790016

NOVEL COMPOSITIONS, USES AND METHODS FOR MAKING THEM

IPC classification:
A61K 31/4353, A61P 35/00, C07D 487/14
Agent:
dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION IN PROGRESS
EP16181415

MONOMERIC RECOMBINANT MHC MOLECULES USEFUL FOR MANIPULATION OF ANTIGEN-SPECIFIC T CELLS

IPC classification:
A61K 39/00
Applicant:
Oregon Health & Science University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION PUBLISHED
EP15796824

USE OF MICROPEROXIDASES FOR THE TREATMENT OF CARBOXYHEMOGLOBINEMIA

IPC classification:
A61K 31/409, A61K 38/04, A61P 7/00
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15796000

METHODS AND COMPOSITIONS FOR REDUCING CLOSTRIDIUM DIFFICILE INFECTION

IPC classification:
A61K 35/74, C12Q 1/26
Applicant:
Memorial Sloan Kettering Cancer Center
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15727165

MATE-PAIR SEQUENCES FROM LARGE INSERTS

IPC classification:
C12N 15/10, C12N 15/64
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15798937

THERAPEUTIC COMPOSITIONS INCLUDING THERAPEUTIC SMALL MOLECULES AND USES THEREOF

IPC classification:
C07K 16/00, C12P 21/08
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP16186448

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPTHALMIC CONDITIONS

IPC classification:
A61K 38/07, A61P 27/02, A61P 27/12
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION PUBLISHED
EP15732925

AGENTS AND METHODS FOR DETERMINING COLORECTAL CANCER STATUS

IPC classification:
A61K 49/00, A61P 35/00, G01N 33/574, A61K 47/50
Applicant:
Oxford University Innovation Ltd
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15799855

METHODS FOR ALTERING POLYPEPTIDE EXPRESSION

IPC classification:
C12N 15/82
Applicant:
The Trustees of Columbia University in the City of New York
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15811659

COVALENTLY BONDED DIABODIES HAVING IMMUNOREACTIVITY WITH PD-1 AND LAG-3, AND METHODS OF USE THEREOF

IPC classification:
C07K 16/28
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15818902

USE OF A GUT MICROBIOME AS A PREDICTOR OF ANIMAL GROWTH OR HEALTH

IPC classification:
G06F 19/00
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP16190808

MITOCHONDRIAL-TARGETED ANTIOXIDANTS PROTECT AGAINST MECHANICAL VENTILATION-INDUCED DIAPHRAGM DYSFUNCTION AND SKELETAL MUSCLE ATROPHY

IPC classification:
A61K 38/06, A61P 21/00, A61P 39/06
Applicant:
Cornell University
Applicant:
University of Florida Research Foundation, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION PUBLISHED
EP16192386

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT NEUROPATHY

IPC classification:
A61K 38/07
Applicant:
Stealth Peptides International, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
APPLICATION PUBLISHED
EP15744639

MEASUREMENT OF ANALYTES WITH MEMBRANE CHANNEL MOLECULES, AND BILAYER ARRAYS

IPC classification:
C12Q 1/68, G01N 33/48
Applicant:
Oxford University Innovation Ltd
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP14898110

PHOTOVOLTAIC MODULE ACCESSORY CLAMP

IPC classification:
H02S 20/00
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15827008

HUMAN MONOCLONAL ANTIBODIES AGAINST EPHA4 AND THEIR USE

IPC classification:
A61K 39/395
Applicant:
Hong Kong University of Science and Technology
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15828982

ELASTIC BIOPOLYMER AND USE AS A TISSUE ADHESIVE

IPC classification:
A61L 24/04
Applicant:
The Brigham and Women's Hospital, Inc.
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15757006

STEM CELL COMPOSITIONS AND METHODS OF PRODUCING STEM CELLS FOR THERAPEUTIC APPLICATIONS

IPC classification:
C12N 5/073, C12N 5/0775
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15838601

PURE CHELATION PROCESS

IPC classification:
A61K 31/28, B01J 45/00, C07F 1/08, C07F 3/06, C07F 13/00, C07F 15/04, C07F 15/06
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
Request for examination was made
EP15837740

GLOBIN GENE THERAPY FOR TREATING HEMOGLOBINOPATHIES

IPC classification:
C12N 15/113
Applicant:
The University of Washington
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
Request for examination was made
EP15839453

CONVERTIBLE MOTORIZED RUNNING CYCLE

IPC classification:
B62M 6/40
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
Request for examination was made
EP15771998

CELL CULTURE SUBSTRATE

IPC classification:
C12N 5/00, C12N 5/077
Applicant:
University of Nottingham
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
Request for examination was made
EP15766930

MODIFIED SPIDER SILK

IPC classification:
C07K 14/435
Applicant:
University of Nottingham
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
Request for examination was made
EP15842612

METHODS FOR TREATING BRAIN METASTASIS

IPC classification:
A01K 67/00, A61K 31/337, A61K 31/4188
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
Request for examination was made
EP15842027

METHODS AND DEVICES FOR DETECTING AND IDENTIFYING MICROORGANISMS

IPC classification:
C12Q 1/68
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
Request for examination was made
EP15833686

TUMOR NECROSIS FACTOR SUPERFAMILY AND TNF-LIKE LIGAND MUTEINS AND METHODS OF PREPARING AND USING THE SAME

IPC classification:
A61K 45/00, C07K 1/00
Applicant:
The General Hospital Corporation
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
Request for examination was made
EP15845450

COMPOSITIONS AND METHODS FOR TRANSIENT IMMUNE RESPONSE MODULATION DURING VACCINATION

IPC classification:
A61K 39/21, A61P 37/02
Applicant:
Duke University
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
Request for examination was made
EP15821594

METHODS OF TREATING CELLS CONTAINING FUSION GENES

IPC classification:
A61K 48/00, A61P 35/00, C12Q 1/68
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
Request for examination was made
EP15844698

BI-SPECIFIC MONOVALENT DIABODIES THAT ARE CAPABLE OF BINDING CD19 AND CD3, AND USES THEREOF

IPC classification:
C07K 16/28
Agent:
Jennifer Atkinson, Barker Brettell LLP
Status:
Request for examination was made

Please Sign in to use this feature